The Importance of Research at Henderson Behavioral Health

Research paves the way for prevention, recovery and cure and HBH is committed to contributing to that knowledge base. HBH participates in cutting-edge research on evidence based practices, emerging best practices and recovery-promoting services for individuals with severe mental illness. Systematic pursuit and dissemination of such knowledge, has been a cornerstone of HBH’s long history.

  • HBH participated in its first NIMH-funded project entitled “Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Study.” This was a 5 year nationwide, public health-focused clinical trial that compared the effectiveness of older (first available in the 1950s) and newer (available since the 1990s) antipsychotic medications used to treat schizophrenia. HBH was one of 57 clinical sites around the nation that helped explore this question. The study had vital public health implications because it provided doctors and patients with much-needed information comparing medication treatment options. It was the largest, longest, and most comprehensive independent trial ever done to examine existing therapies for this disease.
  • From 2006 to 2010, HBH was selected as one of only 20 sites for the “Mental Health Treatment Study,” sponsored by the Social Security Administration. Henderson was selected for the study on the basis of its historical performance with evidence-based supported employment. The 4-year study concluded in July 2010, and examined the value of eliminating disincentives from the workplace, establishing an accurate diagnosis and delivering appropriate mental health and employment supports for study participants. Outcomes assessed included employment, health and mental status, quality of life, functioning, and clinical recovery. Study participants were selected from Social Security Disability Insurance beneficiaries and had a primary impairment of schizophrenia or affective disorder. Westat, an employee-owned research corporation based in Rockville, MD, conducted the study, along with Dartmouth University, the University of Texas, the University of Maryland at Baltimore County and Indiana University-Purdue University Indianapolis.

Currently, HBH is involved in four critical studies:

  • In October 2012, Henderson Behavioral Health has been awarded a four-year, $1.6 million Primary Health/Behavioral Health Integration Grant from the Center for Mental Health Services of the Department of Health and Human Services Substance Abuse and Mental Health Services Administration. The funding is specifically intended to bring Primary Healthcare on-site and integrated at Henderson Behavioral Health. People with serious mental illnesses die, on average, 25 years earlier than the general population, largely from preventable and treatable chronic health care conditions. This grant will address this issue with the goal of improving the physical health status of adults with serious mental illnesses (SMI) who have or are at risk for co-occurring primary care conditions and chronic diseases, with the objective of supporting the triple aim of improving the health of those with SMI; the consumer's experience of care (including quality, access, and reliability); and reducing/controlling the per capita cost of care.
  • Begun in April, 2012, the Improve Care and Reduce Cost, or ICRC study, is to improve disease management and the overall process of care in treating schizophrenia in order to reduce ER visits and hospital days while providing better care and better health. This will be done by fostering innovation in the use of technology and by training and deploying Mental Health/Health Technology (MH/HT) Case Managers. The components of the treatment model include: 1) evidence-based pharmacological treatment facilitated by a web-based prescriber decision support system 2) brief, in-person, relapse prevention counseling with supplemental web-based learning modules, 3) Technology to Extend Care and Support to Schizophrenia (TECSS), a program that offers web- and phone-based resources to support persons with schizophrenia and their family members, peers or others 4) an interactive smart phone application to support medication adherence, facilitate coping with symptoms and improve daily functioning in individuals with schizophrenia and 5) a web-based, self-administered cognitive-behavioral therapy (CBT) program for the management of hallucinations and paranoia. This research is funded by CMS (Centers for Medicare & Medicaid Services).
  • In October 2011, Henderson Behavioral Health began participating in a three-year Computerized Cognitive Behavioral Therapy (CCBT) study coordinated by the University of South Florida Rothman Center for Neuropsychiatry. The study is evaluating the efficacy of Computerized Cognitive Behavioral Therapy (CCBT) for childhood anxiety at community mental health centers similar to HBH.
  • In January 2010, Henderson Behavioral Health was selected as one of thirty five leading behavioral healthcare organizations from across the nation, to participate in a new National Institute of Mental Health (NIMH) research study. The study is designed to evaluate the benefits of a comprehensive pharmacological and psychosocial treatment package (referred to as the RAISE Early Treatment Program) for individuals with first episode psychosis, compared to a typical community mental health treatment (community care). The goals of the study are to improve the long-term trajectory of schizophrenia and reduce its disability over the lifetime by providing rapid, comprehensive, effective treatment at the first episode of psychosis. Also, the study seeks to develop and evaluate an intervention for first episode psychosis that can be delivered in a wide range of clinical settings and can be paid for by existing funding mechanisms. The program is led by Dr. John Kane at the Zucker Hillside Hospital in New York with colleagues from Dartmouth Medical School, University of North Carolina at Chapel Hill, Yale Medical School, University of Calgary, UCLA, and SUNY Downstate Medical Center.